Petros Pharmaceuticals, Inc. (PTPI)
PTPI Stock Price Chart
Explore Petros Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PTPI price movements and trends.
PTPI Company Profile
Discover essential business fundamentals and corporate details for Petros Pharmaceuticals, Inc. (PTPI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2 Dec 2020
Employees
18.00
Website
https://www.petrospharma.comCEO
Joshua N. Silverman
Description
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
PTPI Financial Timeline
Browse a chronological timeline of Petros Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
PTPI Stock Performance
Access detailed PTPI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
